D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

GENEVA — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small ...

In a historic medical breakthrough, a three-year-old child has become the youngest patient ever to receive a revolutionary ...